EUVIMEDEUVIMED entdecken
Open Access

Positive predictive value of cervical cancer screening results recommended for colposcopy by human papillomavirus vaccination status at 3 U.S. healthcare systems

Gaia Pocobelli, Jacquelyn Lykken, Jennifer S Haas, Jasmin Tiro, V Paul Doria-Rose, Noorie Hyun, Michelle I Silver, Aruna Kamineni, Jessica Chubak

Cancer Causes & Control · 2025

DOI: 10.1007/s10552-025-02039-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Causes & Control, 2025. Verfasst von Gaia Pocobelli und 8 weiteren Autor:innen. Beteiligte Einrichtung: Kaiser Permanente Washington Health Research Institute, 1730 Minor Avenue, Suite 1360, Seattle, WA, 98101, USA. Gaia.S.Pocobelli@kp.org. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Colposcopy, Papillomavirus Vaccines, Early Detection of Cancer. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Cancer Institute of the National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: The positive predictive value (PPV) of cervical cancer screening was projected to decrease in the era of human papillomavirus (HPV) vaccination. METHODS: We conducted a retrospective cohort study at three U.S. healthcare systems during 2010-2018. Females aged 21-38 years with an abnormal cervical cancer screening test result for which colposcopy was guideline-recommended were included. We estimated age-specific PPVs of cervical intraepithelial neoplasia grade 2 or more severe diagnosis (≥ CIN 2) in HPV-vaccinated and unvaccinated females. RESULTS: The age-specific PPV point estimates were lower in vaccinated versus unvaccinated females in each age group (21-24; 25-29; and 30-38 years), but the difference was statistically significant only among 25-29-year-olds (PPV = 16.4% [95% CI (confidence interval), 14.6-18.4%] and PPV = 19.8% [95% CI 18.5-21.1%], respectively). Among vaccinated 25-29-year-olds, the PPV was lower in those who received their first dose at ≤ 20 versus > 20 years of age (PPV = 12.1% [95% CI 9.5-15.2%] and PPV = 18.8% [95% CI 16.4-21.4%], respectively). Among all age groups combined, the PPV was lower in vaccinated versus unvaccinated females. CONCLUSIONS: Our findings suggest that among females with a cervical test result recommended for colposcopy, the PPV for ≥ CIN2 was lower in those vaccinated versus unvaccinated, and was relatively lower in those vaccinated at younger ages. Future studies will have greater ability to estimate the impact of vaccination at the recommended age (9-12 years) on the PPV as more recent birth cohorts, who had greater vaccine uptake, age-in to screening eligibility.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsColposcopyPapillomavirus VaccinesEarly Detection of CancerPapillomavirus InfectionsUterine Cervical DysplasiaHumansFemaleAdultRetrospective StudiesYoung AdultUnited StatesPredictive Value of TestsVaccinationPapillomaviridaeHuman Papillomavirus Viruses

Stichwörter der Autor:innen

Cervical cancerCervical squamous intraepithelial neoplasiaHuman papillomavirus vaccinationPositive predictive valueScreening

Substanzen

Papillomavirus Vaccines

Autor:innen und Institutionen

  • Kaiser Permanente Washington Health Research Institute, 1730 Minor Avenue, Suite 1360, Seattle, WA, 98101, USA. Gaia.S.Pocobelli@kp.org.
  • Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Division of General Internal Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Department of Public Health Sciences, University of Chicago Biological Sciences Division, Chicago, IL, USA.
  • Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA.
  • Kaiser Permanente Washington Health Research Institute, 1730 Minor Avenue, Suite 1360, Seattle, WA, 98101, USA.

Förderung

  • NCI NIH HHS
  • National Cancer Institute of the National Institutes of Health

Zitieren

APA

Pocobelli, G., Lykken, J., Haas, J. S., Tiro, J., Doria-Rose, V. P., Hyun, N., Silver, M. I., Kamineni, A., & Chubak, J. (2025). Positive predictive value of cervical cancer screening results recommended for colposcopy by human papillomavirus vaccination status at 3 U.S. healthcare systems. Cancer Causes & Control. https://doi.org/10.1007/s10552-025-02039-7

Vancouver

Pocobelli G, Lykken J, Haas JS, Tiro J, Doria-Rose VP, Hyun N, et al. Positive predictive value of cervical cancer screening results recommended for colposcopy by human papillomavirus vaccination status at 3 U.S. healthcare systems. Cancer Causes & Control. 2025. doi:10.1007/s10552-025-02039-7

BibTeX
@article{Pocobelli2025,
  author = {Pocobelli, Gaia and Lykken, Jacquelyn and Haas, Jennifer S and Tiro, Jasmin and Doria-Rose, V Paul and Hyun, Noorie and Silver, Michelle I and Kamineni, Aruna and Chubak, Jessica},
  title = {Positive predictive value of cervical cancer screening results recommended for colposcopy by human papillomavirus vaccination status at 3 U.S. healthcare systems},
  journal = {Cancer Causes & Control},
  year = {2025},
  doi = {10.1007/s10552-025-02039-7}
}
Kostenlos starten →